Matthew K Fust's Net Worth
Matthew K Fust's net worth is estimated to be at least $9,070,692.69 as of 11/08/2024. CoreStreet's estimation of Matthew K Fust's net worth is based on their sale of stock and current holding of stock.
Matthew K Fust is Director at Neumora Therapeutics, Inc. Common Stock. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 14,049 units of NMRA stock on 10/18/2024. Their biggest sale was on 03/20/2024 when they sold 60,000 units of Crinetics Pharmaceuticals Inc stock for $2,648,400.00. They typically trade 2 times per year.
Total value of insider buys:
- $100,620.00
Total value of insider sells:
- $8,970,072.69
Most recent insider trade:
- Oct. 18, 2024
Matthew K Fust's Insider Trading History
| Neumora Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 18, 2024 | Director | 14,049 | $17.03 | Sell | $239,254.47 |
| Crinetics Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 20, 2024 | Director | 60,000 | $44.14 | Sell | $2,648,400.00 |
July 13, 2022 | Director | 5,700 | $20.96 | Sell | $119,472.00 |
Nov. 1, 2021 | Director | 8,954 | $25.50 | Sell | $228,327.00 |
Sept. 8, 2021 | Director | 6,046 | $25.50 | Sell | $154,173.00 |
July 26, 2021 | Director | 5,000 | $19.59 | Sell | $97,950.00 |
July 19, 2021 | Director | 5,000 | $19.50 | Sell | $97,500.00 |
July 12, 2021 | Director | 5,000 | $20.71 | Sell | $103,550.00 |
Dec. 16, 2019 | Director | 3,500 | $22.50 | Sell | $78,750.00 |
| Ultragenyx | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 7, 2024 | Director | 12,195 | $50.88 | Sell | $620,481.60 |
July 6, 2020 | Director | 6,181 | $90.00 | Sell | $556,290.00 |
July 1, 2020 | Director | 5,000 | $85.00 | Sell | $425,000.00 |
May 30, 2018 | Director | 6,319 | $72.00 | Sell | $454,968.00 |
| Atara Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 4, 2021 | Director | 13,354 | $19.50 | Sell | $260,403.00 |
May 14, 2018 | Director | 12,286 | $43.57 | Sell | $535,301.02 |
| Journey Medical Corporation Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 12, 2019 | Director | 3,000 | $12.00 | Sell | $36,000.00 |
Sept. 12, 2019 | Director | 6,000 | $8.77 | Sell | $52,620.00 |
Oct. 19, 2018 | Director | 4,000 | $13.75 | Sell | $55,000.00 |
Nov. 25, 2014 | Director | 6,000 | $16.77 | Buy | $100,620.00 |
| MacroGenics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 6, 2019 | Director | 6,924 | $29.38 | Sell | $203,427.12 |
| Amgen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 26, 2013 | CFO | 6,043 | $130.50 | Sell | $788,611.50 |
July 2, 2013 | CFO | 1,551 | $132.80 | Sell | $205,972.80 |
May 13, 2013 | CFO | 10,269 | $98.22 | Sell | $1,008,621.18 |